Shiraishi Makoto, Sowa Yoshihiro, Tsuge Itaru, Kodama Takuya, Inafuku Naoki, Morimoto Naoki
Department of Plastic and Reconstructive Surgery, University Hospital Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Mie University, Mie, Japan.
Front Oncol. 2022 May 23;12:815498. doi: 10.3389/fonc.2022.815498. eCollection 2022.
Breast reconstruction is a promising surgical technique to improve health-related quality of life (HRQoL) in patients with breast cancer. However, the long-term risk factors associated with HRQoL after breast surgery are still unclear. Our aim was to evaluate breast satisfaction and HRQoL following breast reconstruction to identify clinical factors associated with each domain of BREAST-Q in the long-term.
Patient-reported BREAST-Q outcomes were analyzed 1 and 5 years after breast reconstruction in a single-blinded, prospective study. Multiple regression analysis was performed to identify the risk and protective factors associated with BREAST-Q scores. These scores at 1 and 5 years were also compared across three types of operation: mastectomy only, tissue expander/implant (TE/Imp), and a deep inferior epigastric perforator (DIEP) flap.
Surveys were completed by 141 subjects after 1 year and 131 subjects after 5 years. Compared to mastectomy only, breast reconstruction was significantly associated with greater "Satisfaction with breasts" (TE/Imp, p < 0.001; DIEP, p < 0.001) and "Psychosocial well-being" (TE/Imp, p < 0.001; DIEP, p < 0.001), higher body mass index (BMI) resulted in lower "Satisfaction with breasts" (p = 0.004), and a history of psychiatric or neurological medication was significantly associated with "Physical well-being" at 1-year postoperatively (p = 0.02). At 5 years, reconstructive procedures were significantly positively associated with greater "Satisfaction with breasts" (TE/Imp, p < 0.001; DIEP, p < 0.001) and "Psychosocial well-being" (TE/Imp, p = 0.03; DIEP, p < 0.001), and a bilateral procedure was a significant risk factor for lower "Psychosocial well-being" (p = 0.02).
The results of this study show that breast reconstruction improves "Satisfaction with Breasts" and "Psychosocial well-being" compared to mastectomy. Among all three types of operation, DIEP gave the best scores at 5 years postoperatively. Thus, autologous reconstruction is recommended for promotion of long-term HRQoL after breast surgery.
乳房重建是一种有前景的外科技术,可改善乳腺癌患者与健康相关的生活质量(HRQoL)。然而,乳房手术后与HRQoL相关的长期风险因素仍不清楚。我们的目的是评估乳房重建后的乳房满意度和HRQoL,以确定长期与BREAST-Q各领域相关的临床因素。
在一项单盲前瞻性研究中,对乳房重建后1年和5年患者报告的BREAST-Q结果进行分析。进行多元回归分析以确定与BREAST-Q评分相关的风险和保护因素。还对仅行乳房切除术、组织扩张器/植入物(TE/Imp)和腹壁下深动脉穿支(DIEP)皮瓣三种手术类型在1年和5年时的这些评分进行了比较。
141名受试者在1年后完成了调查,131名受试者在5年后完成了调查。与仅行乳房切除术相比,乳房重建与更高的“对乳房的满意度”(TE/Imp,p<0.001;DIEP,p<0.001)和“心理社会幸福感”(TE/Imp,p<0.001;DIEP,p<0.001)显著相关,较高的体重指数(BMI)导致较低的“对乳房的满意度”(p=0.004),并且精神或神经药物治疗史与术后1年的“身体幸福感”显著相关(p=0.02)。在5年时,重建手术与更高的“对乳房的满意度”(TE/Imp,p<0.001;DIEP,p<0.001)和“心理社会幸福感”(TE/Imp,p=0.03;DIEP,p<0.001)显著正相关,双侧手术是较低“心理社会幸福感”的一个显著风险因素(p=0.02)。
本研究结果表明,与乳房切除术相比,乳房重建可提高“对乳房的满意度”和“心理社会幸福感”。在所有三种手术类型中,DIEP在术后5年时得分最佳。因此,建议采用自体组织重建以促进乳房手术后的长期HRQoL。